US Trends

what is the best glp1 for weight loss

The short answer is that there is no single “best” GLP‑1 for weight loss for everyone; right now, the strongest overall weight loss results in large trials come from tirzepatide (Zepbound/Mounjaro class) among injectables, while semaglutide (Wegovy, including the new Wegovy pill) remains the best‑established option and the first GLP‑1 pill specifically approved for obesity.

Below is a “Quick Scoop”-style breakdown to match your post format.

What “best GLP‑1” really means

“Best” depends on several factors:

  • How much weight you want or need to lose
  • Your medical history (diabetes, heart disease, GI issues, pregnancy plans, etc.)
  • Whether you prefer weekly shots vs a daily pill
  • Cost, insurance coverage, and long‑term availability

In practice, doctors usually choose between semaglutide‑based and tirzepatide‑based drugs for weight loss in 2026.

Heavy hitters in 2026

1. Tirzepatide (Zepbound / Mounjaro class)

Tirzepatide is technically a dual GIP/GLP‑1 agonist, but it’s in the same family and is often grouped with GLP‑1s in weight‑loss discussions.

  • In late‑stage obesity trials, people on tirzepatide lost up to ~20% of body weight , which is more than typical semaglutide results.
  • Many obesity specialists currently view tirzepatide as the most powerful injectable option for pure weight loss among approved drugs.
  • Downsides: GI side effects (nausea, diarrhea, etc.), possible higher cost/limited coverage in some plans, and it is still a weekly injection.

If someone wants maximum weight loss and can handle a shot , tirzepatide is often considered the top of the list right now.

2. Semaglutide (Wegovy / Ozempic family, including the new pill)

Semaglutide is the most widely used GLP‑1 for weight management, and it now exists as both a weekly shot (Wegovy) and a daily weight‑loss pill (Wegovy pill) in 2026.

  • Obesity trials show around 14–16% average body‑weight loss at higher doses in many participants, which is still a very strong effect.
  • The Wegovy pill just became the first GLP‑1 pill specifically approved for weight loss, with similar weight‑loss efficacy to the injectable in trials.
  • For people who hate injections or have needle anxiety, a once‑daily oral option is a big deal.

If someone wants a well‑studied, proven GLP‑1 with a long track record and the choice of shot or pill , semaglutide is often the go‑to.

3. Other GLP‑1 options (Saxenda, older meds, and emerging drugs)

  • Liraglutide (Saxenda) is a daily injection GLP‑1 also approved for weight loss, but it typically leads to less weight loss than semaglutide or tirzepatide and requires more frequent dosing, so it’s used less as a first choice now.
  • Ozempic (semaglutide) and Mounjaro (tirzepatide) are diabetes‑label drugs sometimes prescribed off‑label for weight loss, depending on local rules and the prescriber.
  • New agents, including stronger multi‑pathway drugs like retatrutide , are in late‑stage trials and have shown nearly 29% weight loss in one study, but they are not yet standard, widely available options.

These are more “niche” or future‑focused options compared with Wegovy/Zepbound today.

Weekly shot vs daily pill: which is “best”?

In 2026, the big shift is the arrival of obesity pills :

  • Injectables (Wegovy, Zepbound):
    • Pros: Strongest overall data; some experts still believe injectables may give slightly better or more consistent weight loss and tolerability for some patients.
* Cons: Need a weekly shot; cost can be high, coverage variable.
  • Oral GLP‑1 pills (Wegovy pill; Eli Lilly pill expected):
    • Pros: Daily pill is more convenient for many; early pricing suggests some doses may be cheaper than injections.
* Cons: Current data suggest **no clear superiority** to injectables for weight loss; some people may have more GI side effects due to daily dosing.

So the “best” form here is more about lifestyle fit and adherence than raw weight‑loss power. If someone is more likely to stick with a pill than an injection (or vice versa), that will matter more than small differences in trial percentages.

Key safety and long‑term realities

A few important forum‑style points people often miss when asking “what is the best GLP‑1 for weight loss”:

  • These medications are intended for people with obesity (BMI ≥ 30) or BMI ≥ 27 with another condition like diabetes, hypertension, or high cholesterol, and they require a prescription and medical supervision.
  • They can have significant side effects (nausea, vomiting, diarrhea, gallbladder issues, rarely pancreatitis) and are not suitable for people with a personal/family history of certain thyroid cancers or multiple endocrine neoplasia type 2.
  • Many people regain weight after stopping GLP‑1 drugs, in some analyses at a faster rate than after behavioral programs alone.
  • Weight lost can include muscle , so resistance training and adequate protein intake are crucial to preserve lean mass, especially for older adults.

So the “best” drug also has to be something you can safely stay on long enough and combine with habits you can keep.

Quick forum‑style verdict

If you were summarizing this as a “Quick Scoop” for your post titled “what is the best glp1 for weight loss” , you could fairly say:

For pure weight‑loss power among approved options, tirzepatide (Zepbound‑class) is now the front‑runner in trials, with average losses around 20% or more, while semaglutide (Wegovy) —now available as both a weekly shot and a daily pill—remains the most established, flexible GLP‑1 choice. The “best” option for any one person depends on their health history, side‑effect tolerance, and whether they’ll stick more reliably with a weekly injection or a daily pill.

Bottom note you can add to your post (tweaked from your template):

Information gathered from public forums or data available on the internet and portrayed here.